Mathews Adera

Company: Ovid Therapeutics

Job title: Vice President, Neurodevelopment


Ovid’s Patient-Driven Approach to the Rapid Development of Meaningful Medicines for Neurodevelopmental Disorders 5:30 pm

Working with rare disease stakeholders to forge efficient collaborations that will positively impact patients Community-powered approaches to boost enrollment & the overall availability of data Ovid’s approach to developing endpoints that are patient-centric Driving effective rare disease policy, access to diagnostics and inclusive educationRead more

day: Day One

Live Q&A Session with Your Expert Speakers 6:00 pm

Read more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.